Basel, Basel, Switzerland
Accomplished Legal Executive with significant achievements and hands-on international experience in advising both rapidly growing biotech Companies and big pharma both as external and in-house counsel. Fluent in English, French and knowledge of German. Expertise includes: • Strategic Transactions and M&A • Corporate Governance and Compliance • Regulatory Strategy and Market Access • Commercialization and Product Advertising • Competitive Strategy and Litigation • Regulatory Compliance and Data Privacy • Clinical Research and Product Development • Employment and Labour Law
Responsible for building, managing and developing the global/cross regional NTO Biologics, Cell & Gene and CMO Legal Team - providing end-to-end legal support to all three platforms.
Leading the NTO Transaction team in addition to my role as Head Legal Biologics, Cell & Gene
Member of the Global Novartis TechOps (NTO) Legal and Compliance (L&C) Leadership Team, acting as lead lawyer for NTO in global transactions / projects in the area of Footprint (expansion, closing, divesting of sites / outsourcing of manufacturing), M&A and BD&L (acquistion, divestment, in- or out-licensing). Supporting the NTO GC in strategic projects and actively contributing to the design and execution of the L&C function’s strategy.
Responsible for all legal and compliance matters and the global HR team within the Evolva Group listed on Swiss SIX.
Responsible for all legal and compliance matters within the Evolva group listed on Swiss SIX
Co-head of Kromann Reumert's Life Science Group. Working with the development and commercialisation of intellectual property rights, including licence agreements, and pharmaceutical law and food law. Clients include large international companies as well as small and medium-sized businesses. I advise on research cooperation, strategic collaborations and the commercialisation of intellectual property rights, and pharmaceutical law, focusing particularly on the regulatory frameworks within the biotech/pharmaceutical and medical technology industries. Extensive experience in advising on licensing and research and development collaborations with international dimensions, and acting as in-house counsel for a long list of life science companies – particularly in relation to regulatory matters.